InvestorsHub Logo
Followers 30
Posts 5067
Boards Moderated 0
Alias Born 01/07/2020

Re: rafunrafun post# 301473

Friday, 09/25/2020 6:11:58 PM

Friday, September 25, 2020 6:11:58 PM

Post# of 426540
raf@ A thought - maybe not bright - but still A Thought :)

Knowing that it's actually Teva - selling Lovaza - you could look at that as a blockage for making a Partner deal with Teva for Vascepa.
-------------------------

But if you turn it around - Teva is 'exactly the right partner for this. Instead of 'fighting Amarin' - loosing Lovaza marked all the time, Teva can go out into the world and announce:

"We now have the wunder drug that over the next months will replace Lovaza - and this drug will be on of the biggest and most important drugs for humanity ever - with potential to save hundreds of millions of CDV patients Worldwide".
--------------------------

Idea: Teva would have 'both groups of customers' from the start. And they could just 'nice and easy' transfer earlier Lovaza patients to Vascepa - in the tempo where logistics and production would be able to handle it.

Teva would benefit - sky would be the limit for expansion of new Vascepa customers WW. CDV patient all over planet earth would benefit - a total WIN - WIN :)

Jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News